PL372748A1 - 2-Tiadibenzoazuleny jako inhibitory wytwarzania czynnika martwiczego nowotworu guza i związki pośrednie do ich wytwarzania - Google Patents

2-Tiadibenzoazuleny jako inhibitory wytwarzania czynnika martwiczego nowotworu guza i związki pośrednie do ich wytwarzania

Info

Publication number
PL372748A1
PL372748A1 PL03372748A PL37274803A PL372748A1 PL 372748 A1 PL372748 A1 PL 372748A1 PL 03372748 A PL03372748 A PL 03372748A PL 37274803 A PL37274803 A PL 37274803A PL 372748 A1 PL372748 A1 PL 372748A1
Authority
PL
Poland
Prior art keywords
thia
intermediates
preparation
necrosis factor
tumour necrosis
Prior art date
Application number
PL03372748A
Other languages
English (en)
Inventor
Mladen Mercep
Milan Mesic
Dijana Pesic
Ivana Ozimec
Original Assignee
Pliva-Istrazivacki Institut D.O.O.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pliva-Istrazivacki Institut D.O.O. filed Critical Pliva-Istrazivacki Institut D.O.O.
Publication of PL372748A1 publication Critical patent/PL372748A1/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/78Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems condensed with rings other than six-membered or with ring systems containing such rings
    • C07D333/80Seven-membered rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL03372748A 2002-04-10 2003-04-09 2-Tiadibenzoazuleny jako inhibitory wytwarzania czynnika martwiczego nowotworu guza i związki pośrednie do ich wytwarzania PL372748A1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HR20020305A HRP20020305A8 (en) 2002-04-10 2002-04-10 2-thia-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof

Publications (1)

Publication Number Publication Date
PL372748A1 true PL372748A1 (pl) 2005-08-08

Family

ID=28686903

Family Applications (1)

Application Number Title Priority Date Filing Date
PL03372748A PL372748A1 (pl) 2002-04-10 2003-04-09 2-Tiadibenzoazuleny jako inhibitory wytwarzania czynnika martwiczego nowotworu guza i związki pośrednie do ich wytwarzania

Country Status (26)

Country Link
US (1) US7435834B2 (pl)
EP (1) EP1509530B1 (pl)
JP (1) JP2005526828A (pl)
CN (1) CN1649875A (pl)
AT (1) ATE320433T1 (pl)
AU (1) AU2003259963A1 (pl)
BR (1) BR0309094A (pl)
CA (1) CA2481514A1 (pl)
CY (1) CY1105036T1 (pl)
DE (1) DE60304048T2 (pl)
DK (1) DK1509530T3 (pl)
ES (1) ES2260637T3 (pl)
HR (1) HRP20020305A8 (pl)
IL (1) IL164396A0 (pl)
IS (1) IS7474A (pl)
MX (1) MXPA04009943A (pl)
NO (1) NO20044506L (pl)
NZ (1) NZ535620A (pl)
PL (1) PL372748A1 (pl)
PT (1) PT1509530E (pl)
RU (1) RU2334749C2 (pl)
SI (1) SI1509530T1 (pl)
UA (1) UA79277C2 (pl)
WO (1) WO2003084962A1 (pl)
YU (1) YU88304A (pl)
ZA (1) ZA200408063B (pl)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP20020304B1 (en) * 2002-04-10 2008-04-30 GlaxoSmithKline istra�iva�ki centar Zagreb d.o.o. 1-oxa-3-aza-dibenzoazulenes as inhibitors of tumor necrosis factor production and intermediates for the production thereof
HRP20020305A8 (en) 2002-04-10 2009-03-31 GlaxoSmithKline istra�iva�ki centar Zagreb d.o.o. 2-thia-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
HRP20020452A2 (en) * 2002-05-23 2004-02-29 Pliva D D 1,2-diaza-dibenzoazulen as inhibitor of production of tumor necrosis factors and intermediates for preparation thereof
HRP20030885A2 (en) * 2003-11-03 2005-08-31 Pliva-Istra�iva�ki institut d.o.o. USE OF 2-THIA-DIBENZO[e,h]AZULENES FOR THE MANUFACTURE OF PHARMACEUTICAL FORMULATIONS FOR THE TREATMENT AND PREVENTION OF CENTRAL NERVOUS SYYTEM DISEASES AND DISORDERS
HRP20030956A2 (en) * 2003-11-21 2005-08-31 Pliva-Istra�iva�ki institut d.o.o. USE OF 1,2-DIAZA-DIBENZO[e,h]AZULENES FOR THE MANU
EP1968583A4 (en) * 2005-12-20 2010-09-15 Harvard College COMPOUNDS, TESTS AND METHODS OF TREATMENT

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3711489A (en) * 1971-03-31 1973-01-16 Pfizer Certain 8,9-dihydro(3,4,7,8)cycloocta(1,2-d)imidazoles
CA967573A (en) 1972-12-22 1975-05-13 Joseph G. Lombardino Tetracyclic anti-inflammatory agents
NL7605526A (nl) * 1976-05-24 1977-11-28 Akzo Nv Nieuwe tetracyclische derivaten.
US4198421A (en) * 1978-11-30 1980-04-15 E. I. Du Pont De Nemours And Company Antiinflammatory 2-substituted-dibenzo[2,3:6,7]oxepino[4,5-d]imidazoles
FR2504140A1 (fr) 1981-04-16 1982-10-22 Centre Nat Rech Scient Nouveaux derives tetracycliques de la dibenzazepine, leur procede de preparation et les compositions pharmaceutiques en renfermant
EP0125484A1 (de) 1983-04-12 1984-11-21 Ciba-Geigy Ag Polycyclische Carbonsäureverbindungen, Verfahren zu ihrer Herstellung und Präparate enthaltend solche Carbonsäureverbindungen, sowie deren Verwendung
IE62754B1 (en) 1988-08-26 1995-02-22 Akzo Nv Tetracyclic antidepressants
IT1227527B (it) 1988-12-05 1991-04-12 Ciatti Maurizio Spazzolino da denti a setole rotanti
US5773433A (en) 1994-11-02 1998-06-30 Janssen Pharmaceutica, N.V. Substituted tetracyclic oxazepine and thiazepine derivatives
US5552399A (en) 1994-11-02 1996-09-03 Janssen Pharmaceutica N.V. Substituted tetracyclic azepine derivatives
US6057441A (en) 1996-04-12 2000-05-02 Janssen Pharmaceutica, N.V. Substituted tetracyclic tetrahydrofuran derivatives
UA52778C2 (uk) 1997-10-10 2003-01-15 Янссен Фармацевтика Н.В. Галогенозаміщені тетрациклічні похідні тетрагідрофурану, спосіб їх отримання та композиція на їх основі
HRP20000310A2 (en) 2000-05-17 2002-02-28 Pliva Farmaceutska Ind Dioniko New dibenzoazulene compounds as tumor necrosis factor inhibitors
HRP20020305A8 (en) 2002-04-10 2009-03-31 GlaxoSmithKline istra�iva�ki centar Zagreb d.o.o. 2-thia-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
HRP20030957A2 (en) 2003-11-21 2005-08-31 Pliva-Istra�iva�ki institut d.o.o. USE OF 1-THIA-3-AZA-DIBENZO[e,h]AZULENES FOR THE MANUFACTURE OF PHARMACEUTICAL FORMULATIONS FOR THE TREATMENT AND PREVENTION OF CENTRAL NERVOUS SYSTEM DISEASES AND DISORDERS
HRP20040104A2 (en) 2004-01-30 2005-10-31 Pliva-Istra�iva�ki institut d.o.o. Use of benzonaphthoazulenes for the manufacture of pharmaceutical formulations for the treatment and prevention of central nervous system diseases and disorders

Also Published As

Publication number Publication date
IS7474A (is) 2004-09-27
ES2260637T3 (es) 2006-11-01
WO2003084962A1 (en) 2003-10-16
HRP20020305A2 (en) 2003-10-31
HRP20020305A8 (en) 2009-03-31
US7435834B2 (en) 2008-10-14
CN1649875A (zh) 2005-08-03
UA79277C2 (en) 2007-06-11
RU2004132868A (ru) 2005-06-10
RU2334749C2 (ru) 2008-09-27
CA2481514A1 (en) 2003-10-16
NO20044506L (no) 2004-11-09
NZ535620A (en) 2006-03-31
ATE320433T1 (de) 2006-04-15
EP1509530A1 (en) 2005-03-02
JP2005526828A (ja) 2005-09-08
DE60304048D1 (de) 2006-05-11
BR0309094A (pt) 2005-02-09
AU2003259963A1 (en) 2003-10-20
PT1509530E (pt) 2006-07-31
IL164396A0 (en) 2005-12-18
DE60304048T2 (de) 2006-10-19
EP1509530B1 (en) 2006-03-15
US20050182126A1 (en) 2005-08-18
YU88304A (sh) 2006-08-17
SI1509530T1 (sl) 2006-08-31
MXPA04009943A (es) 2005-09-30
ZA200408063B (en) 2006-07-26
CY1105036T1 (el) 2010-03-03
DK1509530T3 (da) 2006-07-17

Similar Documents

Publication Publication Date Title
MX368368B (es) Compuestos de indol e indazol como un inhibidor de necrosis celular.
MXPA03006248A (es) Derivados de acido fumarico como inhibidores de nf-kappab.
EA200601358A1 (ru) Новые ингибиторы химазы
AU2003224923A1 (en) Heterocyclic amide derivatives as cytokine inhibitors
UA87822C2 (ru) Производные нафтилена как ингибиторы цитохрома p450
IL164395A0 (en) 1-Or-3-thia-benzonaphthoazulees as inhibitors of tumour necrosis factor production and intermediatesfor the preparation thereof
IL164396A0 (en) 2-Thia-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
RS100104A (en) 1,3-diaza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
MY136938A (en) New process for the synthesis of perindopril and its pharmaceutically acceptable salts
MY138550A (en) Method for synthesis of perindopril and its pharmaceutically acceptable salts
RS100004A (en) 1-thia-3-aza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
RS99404A (en) 1-oxa-dibenzoazulenes as inhibitors of tumour necrosis facto production and intermediates for the preparation thereof
PL372456A1 (pl) 1-oksa-3-azadibenzoazuleny jako inhibitory wytwarzania czynnika martwiczego nowotworu i związki pośrednie do ich wytwarzania
RS100204A (en) 1,2-diaza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
MY135359A (en) New process for the synthesis of perindopril and pharmaceutically acceptable salts thereof
MY149837A (en) New process for the synthesis of perindopril and pharmaceutically acceptable salts thereof

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)